Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  acute myeloid leukemia/transient myeloproliferative disorder
Stage/Subtype:  acute myeloid leukemia/transient myeloproliferative disorder
Country:  U.S.A.
Trial Type:  Treatment
Results 1-1 of 1 for your search:
Start Over
Sorafenib Tosylate, Cytarabine, and Clofarabine in Treating Patients with Refractory or Relapsed Hematologic Malignancies
Phase: Phase I
Type: Treatment
Age: 31 and under
Trial IDs: RELHEM, NCI-2011-01252, NCT00908167
Start Over